R&G Pharmastudies Co.,Ltd.’s Net Profit Rose 13.9% in 2022

R&G Pharmastudies Co.,Ltd. (诺思格(北京)医药科技股份有限公司) (301333.SZ) reported a net profit of 114.3 million yuan in 2022, up 13.9% year-on-year.

Meanwhile, the company posted 637.5 million yuan in revenue, up 4.8% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 287 million yuan in total liabilities, with a liability-to-asset ratio of 15.3%.